Skip to content

Nuvalent, Inc. NUVL Other Non-Current Assets

Other Non-Current Assets at other companies

Summit Therapeutics logo
Summit TherapeuticsSMMT
$8.23M+98.6%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$14.48M+10.3%
Incyte logo
IncyteINCY
$24.49M-18.8%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$94.7M-18.7%
Exelixis logo
ExelixisEXEL
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s other non-current assets?
Nuvalent, Inc. (NUVL) reported other non-current assets of $23.21M in Q1 2026.
How has Nuvalent, Inc.'s other non-current assets changed year-over-year?
Nuvalent, Inc.'s other non-current assets increased by 20.6% year-over-year, from $19.25M to $23.21M.
What is the long-term trend for Nuvalent, Inc.'s other non-current assets?
Over 4 years (2021 to 2025), Nuvalent, Inc.'s other non-current assets has grown at a 58.7% compound annual growth rate (CAGR), from $3.2M to $20.28M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.